These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35566429)

  • 1. Common Variable Immunodeficiency Associated with a De Novo
    Díaz-Alberola I; Espuch-Oliver A; García-Aznar JM; Ganoza-Gallardo C; Aguilera-Franco M; Sampedro A; Jiménez P; López-Nevot MÁ
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.
    Arroyo-Sánchez D; Cabrera-Marante O; Laguna-Goya R; Almendro-Vázquez P; Carretero O; Gil-Etayo FJ; Suàrez-Fernández P; Pérez-Romero P; Rodríguez de Frías E; Serrano A; Allende LM; Pleguezuelo D; Paz-Artal E
    J Clin Immunol; 2022 Feb; 42(2):240-252. PubMed ID: 34787773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.
    La Civita E; Zannella C; Brusa S; Romano P; Schettino E; Salemi F; Carrano R; Gentile L; Punziano A; Lagnese G; Spadaro G; Franci G; Galdiero M; Terracciano D; Portella G; Loffredo S
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37632002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Functional Relevance of Variants in the
    Eskandarian Z; Fliegauf M; Bulashevska A; Proietti M; Hague R; Smulski CR; Schubert D; Warnatz K; Grimbacher B
    Front Immunol; 2019; 10():568. PubMed ID: 31057532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency.
    Goda V; Kriván G; Kulcsár A; Gönczi M; Tasnády S; Matula Z; Nagy G; Bekő G; Horváth M; Uher F; Szekanecz Z; Vályi-Nagy I
    Front Immunol; 2022; 13():907125. PubMed ID: 35784359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
    Quinti I; Locatelli F; Carsetti R
    Front Immunol; 2021; 12():815404. PubMed ID: 35126372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients.
    Barrios Y; Franco A; Alava-Cruz C; Cuesta-Martin R; Camara C; Matheu V
    Allergol Immunopathol (Madr); 2022; 50(3):101-105. PubMed ID: 35527662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency.
    Kralickova P; Jankovicova K; Sejkorova I; Soucek O; Koprivova K; Drahosova M; Andrys C; Krejsek J
    Int Arch Allergy Immunol; 2022; 183(12):1297-1310. PubMed ID: 36202084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Memory B-Cell Response to Influenza Immunization in Patients With Common Variable Immunodeficiency (CVID).
    Zhan W; Hatchette T; Yue F; Liu J; Song H; Zhao H; Betschel S; Ostrowski M
    Pathog Immun; 2021; 6(2):105-118. PubMed ID: 34988341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.
    Milota T; Smetanova J; Skotnicova A; Rataj M; Lastovicka J; Zelena H; Parackova Z; Fejtkova M; Kanderova V; Fronkova E; Rejlova K; Sediva A; Kalina T
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):306-314.e2. PubMed ID: 36379409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.
    Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
    J Clin Immunol; 2021 Jan; 41(1):1-10. PubMed ID: 33392855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response.
    Filippini F; Giacomelli M; Bazzani C; Fredi M; Semeraro P; Tomasi C; Franceschini F; Caruso A; Cavazzana I; Giagulli C
    BMC Med; 2023 Jun; 21(1):210. PubMed ID: 37316832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel IKZF1 variant in a family with autosomal dominant CVID: A case for expanding exon coverage in inborn errors of immunity.
    Stojkic I; Prince BT; Kuehn HS; Gil Silva AA; Varga EA; Rosenzweig SD; Ramadesikan S; Supinger R; Marhabaie M; Chang P; Mardis ER; Koboldt DC
    Clin Immunol; 2024 Jul; 264():110244. PubMed ID: 38734037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
    Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
    Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
    van Leeuwen LPM; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk F; van Gorp ECM; de Wilt F; Bogers S; Gommers L; Geers D; Bruns AHW; Leavis HL; van Haga JW; Lemkes BA; van der Veen A; de Kruijf-Bazen SFJ; van Paassen P; de Leeuw K; van de Ven AAJM; Verbeek-Menken PH; van Wengen A; Arend SM; Ruten-Budde AJ; van der Ent MW; van Hagen PM; Sanders RW; Grobben M; van der Straten K; Burger JA; Poniman M; Nierkens S; van Gils MJ; de Vries RD; Dalm VASH
    J Allergy Clin Immunol; 2022 Jun; 149(6):1949-1957. PubMed ID: 35421449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline
    Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
    Expert Rev Clin Immunol; 2021 Apr; 17(4):407-416. PubMed ID: 33691560
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine.
    Gupta S; Agrawal S; Sandoval A; Su H; Tran M; Demirdag Y
    J Clin Immunol; 2022 Jul; 42(5):914-922. PubMed ID: 35366743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
    Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
    Bitzenhofer M; Suter-Riniker F; Moor MB; Sidler D; Horn MP; Gschwend A; Staehelin C; Rauch A; Helbling A; Jörg L
    PLoS One; 2022; 17(6):e0268780. PubMed ID: 35679232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
    Boutboul D; Kuehn HS; Van de Wyngaert Z; Niemela JE; Callebaut I; Stoddard J; Lenoir C; Barlogis V; Farnarier C; Vely F; Yoshida N; Kojima S; Kanegane H; Hoshino A; Hauck F; Lhermitte L; Asnafi V; Roehrs P; Chen S; Verbsky JW; Calvo KR; Husami A; Zhang K; Roberts J; Amrol D; Sleaseman J; Hsu AP; Holland SM; Marsh R; Fischer A; Fleisher TA; Picard C; Latour S; Rosenzweig SD
    J Clin Invest; 2018 Jul; 128(7):3071-3087. PubMed ID: 29889099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.